Clinical Approaches to HBV Therapy

Volume 5, Issue 4.

In this podcast Daryl T. Y. Lau, MD, MSc, MPH from Harvard Medical School discussed how to evaluate and mange patients who do not meet treatment criteria, the management of chronic hepatitis B during pregnancy, and how to identify patients appropriate for tenofovir alafenamide (TAF) therapy.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.

New Approaches to the Diagnosis and Management of Chronic HBV Infection

Volume 4, Issue 10.

Drs Kenneth Sherman, MD, PhD and Nadeem Anwar, MD cover the important topic of New Approaches to the Diagnosis and Management of Chronic HBV Infection in the format of case-study scenarios for the clinical practice.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.

Hepatitis C Treatment in the HIV Coinfected and Dialysis Populations

Volume 4, Issue 7.

Drs Paul Martin, MD and Kalyan Ram Bhamidimarri, MD cover the important topic of Hepatitis C Treatment in the HIV Coinfected and Dialysis Populations in the format of case-study scenarios for the clinical practice.

Highlights from the 2014 EASL Meeting

Volume 3, Issue 12.

Mark S. Sulkowski, MD, Professor of Medicine, Medical Director, Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology at the Johns Hopkins University School of Medicine, Raymond T. Chung, Associate Professor of Medicine, Harvard Medical School, Director of Hepatology, Vice Chief of Gastroenterology at Massachusetts General Hospital, and Laurent Castera, MD, PhD, Department of Hepatology, Beaujon Hospital, AP-AP, INSERM U773 at the University of Paris-Diderot. Discuss new information presented at the 2014 European Association for the Study of the Liver (EASL) meeting, as well as non-invasive markers of liver disease.

Susanna Naggie, MD Discussed HBV and HCV Coverage at AASLD

Volume 3, Issue 8.

Susanna Naggie, MD, Professor, Assistant Professor of Medicine, Department of Medicine – Infectious Diseases at Duke University School of Medince discusses the development of new therapies for treating hepatitis C infection, and news about hepatitis B from the 64th meeting of the American Association for the Study of Liver Disease, as well as case-study scenarios for the clinical practice.

Cure of Hepatitis B: Is it Achievable?

Volume 3, Issue 6.

Dr. Fabien Zoulim, MD, PhD, Professor, head of INSERM Viral Hepatitis Laboratory at the Medical School of Lyon, Lyon 1 University, Hepatology Department, Hospices Civils de Lyon in Lyon, France discusses the topic of HBV cure, in the form of case-study scenarios for the clinical practice.

The Role of Prediction Models: Best practices in Identifying Cirrhosis and HCC in Patients Infected with HBV

Volume 3, Issue 4.

Dr. Anna Suk-Fong Lok, MD, FRCP, Professor in the Department of Internal Medicine and Director of Clinical Hepatology in the Division of Gastroenterology at the University of Michigan Health System discusses predictive models for cirrhosis in the form of case-study scenarios for the clinical practice.